Management of comorbid medical conditions in schizophrenia

Jeffrey T. Rado*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Patients with schizophrenia endure a markedly greater medical disease burden than the general population. In particular, cardiovascular and metabolic diseases are highly prevalent and lead to an increased overall mortality. The causes are multifactorial and include lifestyle factors (e.g., poor dietary habits), obstacles related to health care delivery, and the adverse effects of antipsychotic medications. The role of these various factors on the physical health of patients with schizophrenia and practical approaches to their management are discussed in this chapter, as well as the prevalence and management of non-cardiometabolic diseases, such as cancer and infectious diseases. The role of medication and the impact of these diseases on medication selection are discussed in more detail in Chap. 12.

Original languageEnglish (US)
Title of host publicationSchizophrenia
Subtitle of host publicationRecent Advances in Diagnosis and Treatment
PublisherSpringer New York
Pages175-204
Number of pages30
ISBN (Electronic)9781493906567
ISBN (Print)1493906550, 9781493906550
DOIs
StatePublished - Feb 1 2014

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Management of comorbid medical conditions in schizophrenia'. Together they form a unique fingerprint.

Cite this